Cargando…

Amyotrophic lateral sclerosis in Beijing: Epidemiologic features and prognosis from 2010 to 2015

OBJECTIVE: To determine the incidence of amyotrophic lateral sclerosis (ALS) in Beijing from 2010 to 2015 and to address the issue of prognosis. METHODS: The number of patients diagnosed with ALS was generated from two aspects, namely, diagnostic hospitals and assisted care institutions. By examinin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Shenghan, Zhou, Yuliang, Qian, Silin, Chang, Wenbing, Wang, Liping, Fan, Dongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236245/
https://www.ncbi.nlm.nih.gov/pubmed/30338660
http://dx.doi.org/10.1002/brb3.1131
_version_ 1783370994708119552
author Zhou, Shenghan
Zhou, Yuliang
Qian, Silin
Chang, Wenbing
Wang, Liping
Fan, Dongsheng
author_facet Zhou, Shenghan
Zhou, Yuliang
Qian, Silin
Chang, Wenbing
Wang, Liping
Fan, Dongsheng
author_sort Zhou, Shenghan
collection PubMed
description OBJECTIVE: To determine the incidence of amyotrophic lateral sclerosis (ALS) in Beijing from 2010 to 2015 and to address the issue of prognosis. METHODS: The number of patients diagnosed with ALS was generated from two aspects, namely, diagnostic hospitals and assisted care institutions. By examining the consistency of the overlapping data in terms of age and gender distributions, the number of ALS patients in Beijing was estimated to analyze the incidence. Finally, a prognosis study was carried out by sorting the clinical data of deceased patients to associate time to death with the demographic characteristics, including gender, age at diagnosis, site of onset, body mass index, and lag from onset to diagnosis. RESULTS: The average yearly incidence was 0.8/100,000 persons, the male–female ratio was 1.63:1, and the mean age at diagnosis was 54.11 years. The mean time from symptom onset to diagnosis was 14.8 months, and the median survival time from diagnosis was 49.4 months. In addition, each of the identified clinical features was related to the survival of the patients with ALS. CONCLUSIONS: The incidence of ALS in Beijing is similar to the rates in Hong Kong and Taiwan but is lower than the rates in Europe and America. In addition, the mean age at onset of the patients in Beijing was early, and overall ALS prognosis appears to be comparable to those reported in recent publications.
format Online
Article
Text
id pubmed-6236245
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62362452018-11-20 Amyotrophic lateral sclerosis in Beijing: Epidemiologic features and prognosis from 2010 to 2015 Zhou, Shenghan Zhou, Yuliang Qian, Silin Chang, Wenbing Wang, Liping Fan, Dongsheng Brain Behav Original Research OBJECTIVE: To determine the incidence of amyotrophic lateral sclerosis (ALS) in Beijing from 2010 to 2015 and to address the issue of prognosis. METHODS: The number of patients diagnosed with ALS was generated from two aspects, namely, diagnostic hospitals and assisted care institutions. By examining the consistency of the overlapping data in terms of age and gender distributions, the number of ALS patients in Beijing was estimated to analyze the incidence. Finally, a prognosis study was carried out by sorting the clinical data of deceased patients to associate time to death with the demographic characteristics, including gender, age at diagnosis, site of onset, body mass index, and lag from onset to diagnosis. RESULTS: The average yearly incidence was 0.8/100,000 persons, the male–female ratio was 1.63:1, and the mean age at diagnosis was 54.11 years. The mean time from symptom onset to diagnosis was 14.8 months, and the median survival time from diagnosis was 49.4 months. In addition, each of the identified clinical features was related to the survival of the patients with ALS. CONCLUSIONS: The incidence of ALS in Beijing is similar to the rates in Hong Kong and Taiwan but is lower than the rates in Europe and America. In addition, the mean age at onset of the patients in Beijing was early, and overall ALS prognosis appears to be comparable to those reported in recent publications. John Wiley and Sons Inc. 2018-10-19 /pmc/articles/PMC6236245/ /pubmed/30338660 http://dx.doi.org/10.1002/brb3.1131 Text en © 2018 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Zhou, Shenghan
Zhou, Yuliang
Qian, Silin
Chang, Wenbing
Wang, Liping
Fan, Dongsheng
Amyotrophic lateral sclerosis in Beijing: Epidemiologic features and prognosis from 2010 to 2015
title Amyotrophic lateral sclerosis in Beijing: Epidemiologic features and prognosis from 2010 to 2015
title_full Amyotrophic lateral sclerosis in Beijing: Epidemiologic features and prognosis from 2010 to 2015
title_fullStr Amyotrophic lateral sclerosis in Beijing: Epidemiologic features and prognosis from 2010 to 2015
title_full_unstemmed Amyotrophic lateral sclerosis in Beijing: Epidemiologic features and prognosis from 2010 to 2015
title_short Amyotrophic lateral sclerosis in Beijing: Epidemiologic features and prognosis from 2010 to 2015
title_sort amyotrophic lateral sclerosis in beijing: epidemiologic features and prognosis from 2010 to 2015
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236245/
https://www.ncbi.nlm.nih.gov/pubmed/30338660
http://dx.doi.org/10.1002/brb3.1131
work_keys_str_mv AT zhoushenghan amyotrophiclateralsclerosisinbeijingepidemiologicfeaturesandprognosisfrom2010to2015
AT zhouyuliang amyotrophiclateralsclerosisinbeijingepidemiologicfeaturesandprognosisfrom2010to2015
AT qiansilin amyotrophiclateralsclerosisinbeijingepidemiologicfeaturesandprognosisfrom2010to2015
AT changwenbing amyotrophiclateralsclerosisinbeijingepidemiologicfeaturesandprognosisfrom2010to2015
AT wangliping amyotrophiclateralsclerosisinbeijingepidemiologicfeaturesandprognosisfrom2010to2015
AT fandongsheng amyotrophiclateralsclerosisinbeijingepidemiologicfeaturesandprognosisfrom2010to2015